The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials

HJ de Koning; ED Crawford; V Nelen; M Kwiatkowski; M Zappa; M Luján; A Villers; TM de Carvalho; EJ Feuer; A Tsodikov; AB Mariotto; R Gulati; EAM Heijnsdijk; R Etzioni; SM Moss; J Hugosson; PF Pinsky; CD Berg; A Auvinen; GL Andriole; MJ Roobol

doi:10.1002/cncr.31178

The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials

HJ de Koning, ED Crawford, V Nelen, M Kwiatkowski, M Zappa, M Luján, A Villers, TM de Carvalho, EJ Feuer, A Tsodikov, AB Mariotto, R Gulati, EAM Heijnsdijk, R Etzioni, SM Moss, J Hugosson, PF Pinsky, CD Berg, A Auvinen, GL AndrioleMJ Roobol

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

56 Sitaatiot (Scopus)

Alkuperäiskieli	Englanti
Julkaisu	Cancer
DOI - pysyväislinkit	https://doi.org/10.1002/cncr.31178
Tila	Julkaistu - 2017
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Tutkimusalat

modeling
mortality reduction
prostate cancer
prostate-specific antigen (PSA) screening

Julkaisufoorumi-taso

Jufo-taso 2

YK:n kestävän kehityksen tavoitteet

Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:

Pääsy asiakirjaan

10.1002/cncr.31178

Siteeraa tätä

de Koning, HJ., Crawford, ED., Nelen, V., Kwiatkowski, M., Zappa, M., Luján, M., Villers, A., de Carvalho, TM., Feuer, EJ., Tsodikov, A., Mariotto, AB., Gulati, R., Heijnsdijk, EAM., Etzioni, R., Moss, SM., Hugosson, J., Pinsky, PF., Berg, CD., Auvinen, A., ... Roobol, MJ. (2017). The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials. Cancer. https://doi.org/10.1002/cncr.31178

@article{de4fcd43ed2c40a6a3415f8113cc59fd,

title = "The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials",

keywords = "modeling, mortality reduction, prostate cancer, prostate-specific antigen (PSA) screening, modeling, mortality reduction, prostate cancer, prostate-specific antigen (PSA) screening",

author = "{de Koning}, HJ and ED Crawford and V Nelen and M Kwiatkowski and M Zappa and M Luj{\'a}n and A Villers and {de Carvalho}, TM and EJ Feuer and A Tsodikov and AB Mariotto and R Gulati and EAM Heijnsdijk and R Etzioni and SM Moss and J Hugosson and PF Pinsky and CD Berg and A Auvinen and GL Andriole and MJ Roobol",

year = "2017",

doi = "10.1002/cncr.31178",

language = "English",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

}

de Koning, HJ, Crawford, ED, Nelen, V, Kwiatkowski, M, Zappa, M, Luján, M, Villers, A, de Carvalho, TM, Feuer, EJ, Tsodikov, A, Mariotto, AB, Gulati, R, Heijnsdijk, EAM, Etzioni, R, Moss, SM, Hugosson, J, Pinsky, PF, Berg, CD, Auvinen, A, Andriole, GL & Roobol, MJ 2017, 'The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials', Cancer. https://doi.org/10.1002/cncr.31178

TY - JOUR

T1 - The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials

AU - de Koning, HJ

AU - Crawford, ED

AU - Nelen, V

AU - Kwiatkowski, M

AU - Zappa, M

AU - Luján, M

AU - Villers, A

AU - de Carvalho, TM

AU - Feuer, EJ

AU - Tsodikov, A

AU - Mariotto, AB

AU - Gulati, R

AU - Heijnsdijk, EAM

AU - Etzioni, R

AU - Moss, SM

AU - Hugosson, J

AU - Pinsky, PF

AU - Berg, CD

AU - Auvinen, A

AU - Andriole, GL

AU - Roobol, MJ

PY - 2017

Y1 - 2017

KW - modeling

KW - mortality reduction

KW - prostate cancer

KW - prostate-specific antigen (PSA) screening

KW - modeling

KW - mortality reduction

KW - prostate cancer

KW - prostate-specific antigen (PSA) screening

U2 - 10.1002/cncr.31178

DO - 10.1002/cncr.31178

M3 - Article

SN - 0008-543X

JO - Cancer

JF - Cancer

ER -